Autoimmune Hemolytic Anemia
📧 Sign up to get email alerts when something new happens for Autoimmune Hemolytic Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) [Phase 2]
Phase 2 trial evaluating rituximab-based combination chemotherapy in patients with chronic lymphocytic leukemia that did not respond to flud…
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia [Phase 3]
Phase 3 clinical trial evaluating prednisolone with or without the anti-CD20 antibody rituximab for autoimmune hemolytic anemia has complete…
-
CLINICAL_TRIALS research · 2012-10-23Clinical Trial Update: The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
An observational ClinicalTrials.gov update (RITAI Cohort) investigates off-label use of rituximab for autoimmune disorders, including pemphi…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining levamisole with prednisolone for warm autoimmune hemolytic anemia; current sta…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 single-arm pilot study evaluating low-dose rituximab plus standard prednisone for idiopathic autoimmune hemolytic anemia; the trial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias [Phase 2, Phase 3]
This clinical trial investigates combining alemtuzumab and rituximab to treat refractory autoimmune cytopenias, including idiopathic thrombo…
-
CLINICAL_TRIALS trial_result · 2008-09-10Clinical Trial Update: Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease [Phase 2]
A Phase II trial evaluated high-dose cyclophosphamide in patients with severe autoimmune hematologic disease. The study focused on autoimmun…